Trials / Completed
CompletedNCT02209896
BlueWind Reprieve System for the Treatment of PNP
Safety and Performance of the BlueWind Medical Reprieve System for the Treatment of Patients With Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- BlueWind Medical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The BlueWind Reprieve system is a neurostimulator consisting of an Implant and external components. The system is intended for home care use. The chronic pain treatment is achieved by an electrical stimulation of peripheral nerve fibers. The stimulation is set so that it generates paresthesia in the stimulated area (e.g. foot), reducing the pain sensation and improving the quality of life for the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The Reprieve system | BlueWind Medical neurostimulator for the treatment of neuropathic pain |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2014-08-06
- Last updated
- 2018-04-11
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT02209896. Inclusion in this directory is not an endorsement.